Initiation of a Phase III Clinical Study of BON-001 for Nausea and Vomiting of Pregnancy in Japan
BLAINVILLE, QC, Oct. 26, 2026 /CNW/ -- Mochida Pharmaceutical Co., Ltd. (Head Office: Shinjuku-ku, Tokyo, Japan; President: Naoyuki Mochida; hereinafter "Mochida") and Duchesnay In…